JPMORGAN CHASE & CO - AADI BIOSCIENCE INC ownership

AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 69 filers reported holding AADI BIOSCIENCE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AADI BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$51,052
-44.1%
10,548
-21.1%
0.00%
Q2 2023$91,396
+14.2%
13,362
+20.1%
0.00%
Q1 2023$80,000
+76090.5%
11,128
+35.2%
0.00%
Q4 2022$105
-99.9%
8,232
+4.0%
0.00%
Q3 2022$112,000
+17.9%
7,913
+2.2%
0.00%
Q2 2022$95,0007,7420.00%
Other shareholders
AADI BIOSCIENCE INC shareholders Q3 2022
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 26,666$193,06217.76%
Alerce Investment Management, L.P. 1,630,830$11,807,20915.60%
ACUTA CAPITAL PARTNERS, LLC 1,849,402$13,389,6709.86%
Decheng Capital Management III (Cayman), LLC 526,329$3,810,6221.54%
Knott David M Jr 183,688$1,3300.52%
Vivo Capital, LLC 509,572$6,456,2770.45%
Ghost Tree Capital, LLC 150,000$1,086,0000.32%
Avoro Capital Advisors LLC 2,849,402$20,629,6700.31%
Parkman Healthcare Partners LLC 75,961$549,9580.12%
RA Capital Management 590,218$4,273,1780.10%
View complete list of AADI BIOSCIENCE INC shareholders